Cargando…
FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer
Endocrine therapy for prostate cancer (PCa) mainly inhibits androgen receptor (AR) signaling, due to increased androgen synthesis and AR changes, PCa evolved into castration-resistant prostate cancer (CRPC). The function of Family With Sequence Similarity 64 Member A (FAM64A) and its association wit...
Autores principales: | Zhou, Yingchen, Ou, Longhua, Xu, Jinming, Yuan, Haichao, Luo, Junhua, Shi, Bentao, Li, Xianxin, Yang, Shangqi, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253826/ https://www.ncbi.nlm.nih.gov/pubmed/34215720 http://dx.doi.org/10.1038/s41419-021-03933-z |
Ejemplares similares
-
SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer
por: Wei, Zhengmao, et al.
Publicado: (2022) -
Role of hypermethylated-lncRNAs in the prognosis of bladder cancer patients
por: Luo, Junhua, et al.
Publicado: (2021) -
FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1
por: Zhao, Xinyuan, et al.
Publicado: (2022) -
Fam64a is a novel cell cycle promoter of hypoxic fetal cardiomyocytes in mice
por: Hashimoto, Ken, et al.
Publicado: (2017) -
FAM64A Promotes Osteosarcoma Cell Growth and Metastasis and Is Mediated by miR-493
por: Jiang, Ying, et al.
Publicado: (2020)